ELI LILLY $55.14

up +0.12


21/5/2013 04:21 PM  |  NYSE : LLY  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing

Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
5/15/2013 Conterno Enrique A Sr. VP & Pres., Lilly Diabetes -5,000 $56.15 -6.48%
5/10/2013 Simmons Jeffrey N SVP&Pres.,Elanco Animal Health -10,000 $54.49 -16.19%
5/1/2013 Conterno Enrique A Sr. VP & Pres., Lilly Diabetes -4,698 $55.38 -5.74%
5/1/2013 Simmons Jeffrey N SVP&Pres.,Elanco Animal Health -4,635 $55.38 -6.98%
4/30/2013 Alvarez Ralph Director 152 $56.49 0.88%
4/29/2013 Mahony Susan SVP & Pres., Lilly Oncology -3,500 $56.33 -7.39%
4/15/2013 Conterno Enrique A Sr. VP & Pres., Lilly Diabetes -5,000 $57.10 -6.50%
3/29/2013 Alvarez Ralph Director 157 $54.66 0.92%
3/26/2013 Mahony Susan SVP & Pres., Lilly Oncology -5,000 $56.00 -9.55%
3/12/2013 Lundberg Jan M EVP,Science&Tech and Pres. LRL -19,000 $55.38 -15.93%
2/28/2013 Alvarez Ralph Director 158 $54.18 0.94%
2/8/2013 Ricks David A SVP and Pres, Lilly Bio-Meds -3,000 $53.91 -10.02%
2/5/2013 Rice Derica W EVP-Global Services and CFO -29,646 $54.21 -36.04%
2/1/2013 Conterno Enrique A Sr. VP & Pres., Lilly Diabetes -14,922 $53.69 -16.26%
2/1/2013 LECHLEITER JOHN C Chairman, President, and CEO -62,173 $53.69 -11.75%
2/1/2013 Lundberg Jan M EVP,Science&Tech and Pres. LRL -15,657 $53.69 -11.61%
2/1/2013 Lundberg Jan M EVP,Science&Tech and Pres. LRL -20,725 $53.69 -16.95%
2/1/2013 Mahony Susan SVP & Pres., Lilly Oncology -10,777 $53.69 -23.84%
2/1/2013 Peterson Barton R Sr. VP, Corp. Affairs & Comm. -6,632 $53.69 -14.84%
2/1/2013 Rice Derica W EVP-Global Services and CFO -24,541 $53.69 -22.98%
2/1/2013 Mahony Susan SVP & Pres., Lilly Oncology -5,000 $54.28 -8.71%
2/1/2013 Simmons Jeffrey N SVP&Pres.,Elanco Animal Health -8,181 $53.69 -12.67%
2/1/2013 Tapiero Jacques SVP&Pres., Emerging Markets -8,181 $53.69 -16.70%
1/31/2013 Alvarez Ralph Director 161 $53.44 0.97%
1/30/2013 Tapiero Jacques SVP&Pres., Emerging Markets -15,000 $54.14 -32.37%
1/25/2013 Mahony Susan SVP & Pres., Lilly Oncology 24,594 $53.21 119.27%
1/25/2013 Simmons Jeffrey N SVP&Pres.,Elanco Animal Health 19,735 $53.21 72.60%
1/25/2013 Peterson Barton R Sr. VP, Corp. Affairs & Comm. 16,165 $53.21 112.23%
1/25/2013 Ricks David A SVP and Pres, Lilly Bio-Meds 11,174 $53.21 59.54%
1/25/2013 Tapiero Jacques SVP&Pres., Emerging Markets 19,733 $53.21 74.18%
1/25/2013 Walsh Fionnuala M SVP, Global Quality 3,881 $53.21 79.40%
1/25/2013 Mahony Susan SVP & Pres., Lilly Oncology 1,657 $53.21 36.33%
1/25/2013 Harrington Michael J Senior VP and General Counsel 5,639 $53.21 36.22%
1/25/2013 Fry Stephen F SVP, HR & Diversity 5,124 $53.21 23.67%
1/25/2013 Crowe Maria A President, Mfg. Operations 13,459 $53.21 125.56%
1/25/2013 Barnes Melissa S Chief Eth/Cmpl Ofcr & SVP, ERM 1,367 $53.21 204.95%
1/25/2013 Zakrowski Donald A Chief Accounting Officer 1,300 $53.21 115.66%
1/25/2013 LECHLEITER JOHN C Chairman, President, and CEO 129,075 $53.21 48.20%
1/25/2013 Conterno Enrique A Sr. VP & Pres., Lilly Diabetes 33,017 $53.21 122.23%
1/25/2013 Lundberg Jan M EVP,Science&Tech and Pres. LRL 44,832 $53.21 134.44%
1/25/2013 Walsh Fionnuala M SVP, Global Quality 13,924 $53.21 80.10%
12/3/2012 Zakrowski Donald A Chief Accounting Officer -517 $49.04 -31.51%
12/3/2012 Fry Stephen F SVP, HR & Diversity -1,166 $49.04 -5.11%
12/3/2012 Ricks David A SVP and Pres, Lilly Bio-Meds -865 $49.04 -4.41%
11/30/2012 Alvarez Ralph Director 3,083 $47.03 23.10%
11/30/2012 BISCHOFF WINFRIED F W SIR Director 3,083 $47.03 8.77%
11/30/2012 ESKEW MICHAEL L Director 3,083 $47.03 16.35%
11/30/2012 Fyrwald J Erik Director 3,083 $47.03 8.35%
11/30/2012 GILMAN ALFRED G Director 3,083 $47.03 7.57%
11/30/2012 HOOVER R DAVID Director 3,083 $47.03 16.75%
11/30/2012 HORN KAREN N Director 3,083 $47.03 5.41%
11/30/2012 MARRAM ELLEN R Director 3,083 $47.03 9.61%
11/30/2012 OBERHELMAN DOUGLAS R Director 3,083 $47.03 23.10%
11/30/2012 PRENDERGAST FRANKLYN G Director 3,083 $47.03 6.43%
11/30/2012 SEIFERT KATHI P Director 3,083 $47.03 6.64%
10/1/2012 Tapiero Jacques SVP&Pres., Emerging Markets -4,643 $47.41 -14.86%
8/1/2012 Conterno Enrique A Sr. VP & Pres., Lilly Diabetes -5,000 $44.16 -15.62%
6/14/2012 Tapiero Jacques SVP&Pres., Emerging Markets -2,125 $41.60 -10.18%
6/1/2012 Conterno Enrique A Sr. VP & Pres., Lilly Diabetes -5,000 $40.60 -11.90%
5/18/2012 HANISH ARNOLD C Chief Accounting Officer -1,295 $40.49 -6.80%
5/14/2012 Tapiero Jacques SVP&Pres., Emerging Markets -2,000 $41.04 -8.75%
5/1/2012 Conterno Enrique A Sr. VP & Pres., Lilly Diabetes -5,000 $41.32 -10.64%
4/17/2012 Tapiero Jacques SVP&Pres., Emerging Markets -2,000 $40.00 -8.04%
4/2/2012 Conterno Enrique A Sr. VP & Pres., Lilly Diabetes -5,000 $40.30 -9.61%
3/12/2012 Tapiero Jacques SVP&Pres., Emerging Markets -2,000 $39.60 -7.44%
2/13/2012 Simmons Jeffrey N SVP&Pres.,Elanco Animal Health -7,900 $38.85 -22.52%
2/2/2012 Rice Derica W EVP-Global Services and CFO -3,800 $39.61 -6.33%
2/1/2012 Lundberg Jan M EVP,Science&Tech and Pres. LRL -11,338 $39.74 -25.37%
2/1/2012 Peterson Barton R Sr. VP, Corp. Affairs & Comm. -5,252 $39.74 -25.39%
2/1/2012 Deane Frank M President, Mfg. Operations -15,497 $39.74 -31.31%
2/1/2012 Carmine Bryce D. EVP and Pres, Lilly Bio-Meds -36,463 $39.74 -26.21%
2/1/2012 LECHLEITER JOHN C Chairman, President, and CEO -91,157 $39.74 -19.92%
2/1/2012 ARMITAGE ROBERT A Sr. VP and General Counsel -24,309 $39.74 -20.03%
2/1/2012 Rice Derica W EVP-Global Services and CFO -35,917 $39.74 -31.65%
2/1/2012 Rice Derica W EVP-Global Services and CFO -17,584 $39.85 -22.67%
1/26/2012 Mahony Susan SVP & Pres., Lilly Oncology 3,077 $39.44 11.17%
1/26/2012 LECHLEITER JOHN C Chairman, President, and CEO 59,601 $39.44 33.43%
1/26/2012 Fry Stephen F SVP, HR & Diversity 5,962 $39.44 45.61%
1/26/2012 Conterno Enrique A Sr. VP & Pres., Lilly Diabetes 7,117 $39.44 15.85%
1/26/2012 ARMITAGE ROBERT A Sr. VP and General Counsel 17,709 $39.44 39.31%
1/26/2012 HANISH ARNOLD C Chief Accounting Officer 2,210 $39.44 12.97%
1/26/2012 Mahony Susan SVP & Pres., Lilly Oncology 1,203 $39.44 36.72%
1/26/2012 Nobles Anne Chief Eth/Cmpl Ofcr & SVP, ERM 3,843 $39.44 19.51%
1/26/2012 Ricks David A SVP and Pres, Lilly Bio-Meds 6,948 $39.44 69.93%
1/26/2012 Simmons Jeffrey N SVP&Pres.,Elanco Animal Health 4,686 $39.44 15.42%
1/26/2012 Tapiero Jacques SVP&Pres., Emerging Markets 5,237 $39.44 24.21%
1/26/2012 Walsh Fionnuala M SVP, Global Quality 3,600 $39.44 279.50%
1/26/2012 Walsh Fionnuala M SVP, Global Quality 11,884 $39.44 216.07%
1/26/2012 HANISH ARNOLD C Chief Accounting Officer 2,235 $39.44 13.11%
1/26/2012 Walsh Fionnuala M SVP, Global Quality 11,883 $39.44 216.05%
1/26/2012 Mahony Susan SVP & Pres., Lilly Oncology 1,285 $39.44 39.22%
12/30/2011 HOOVER R DAVID Director 248 $40.74 1.41%
12/12/2011 Carmine Bryce D. EVP and Pres, Lilly Bio-Meds -5,787 $39.10 -10.14%
11/30/2011 OBERHELMAN DOUGLAS R Director 3,990 $36.34 45.34%
11/30/2011 SEIFERT KATHI P Director 3,990 $36.34 9.85%
11/30/2011 HOOVER R DAVID Director 319 $36.34 2.44%
11/30/2011 HOOVER R DAVID Director 3,990 $36.34 29.79%
11/30/2011 PRENDERGAST FRANKLYN G Director 3,990 $36.34 9.54%
11/30/2011 GILMAN ALFRED G Director 3,990 $36.34 11.42%
11/30/2011 MARRAM ELLEN R Director 3,990 $36.34 14.92%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (LLY), click here.
Marketplace
Trading Center